Europe — EMA
Beconase Allergy Hayfever (Beclometasone Dipropionate)
Beconase Allergy Hayfever nasal spray contains Beclometasone Dipropionate, a corticosteroid used to manage allergy symptoms. It helps reduce inflammation in the
Request sourcing
What is Beclometasone Dipropionate?
Beconase Allergy Hayfever nasal spray contains Beclometasone Dipropionate, a corticosteroid used to manage allergy symptoms. It helps reduce inflammation in the nasal passages, providing relief from hayfever and seasonal allergies.
What is Beclometasone Dipropionate used for?
Beconase Allergy Hayfever is primarily used for the treatment of allergic rhinitis, including symptoms like sneezing, itchy nose, and nasal congestion. This nasal spray works by reducing inflammation in the nasal passages, making it effective for managing hayfever and other seasonal allergies. It is often recommended for those seeking relief from persistent allergy symptoms.
What are the side effects of Beclometasone Dipropionate?
Common effects of Beconase Allergy Hayfever may include a mild nasal irritation or dryness. Some users might experience a slight taste or smell after use. These effects are generally temporary and should subside with continued use. If any persistent or severe effects occur, it is advisable to consult a healthcare professional.
What precautions apply to Beclometasone Dipropionate?
Beconase Allergy Hayfever should be used as directed and stored at room temperature. It is important to avoid getting the spray in the eyes. Users with a history of nasal injuries or recent nasal surgery should use this product with caution. Always follow the instructions provided with the medication.
What does Beclometasone Dipropionate interact with?
Beconase Allergy Hayfever may interact with other medications, including certain nasal decongestants. It is advisable to inform your healthcare provider about all medications you are taking. Additionally, avoid using this nasal spray with other corticosteroid medications unless directed by a healthcare professional.



